# FDA 483 - Alison R. Sehgal, MD - December 29, 2020

Source: https://www.keypedia.com/records/483/alison-r-sehgal-md/e297855c-dba4-4202-9903-9378807a4ee8

> FDA 483 for Alison R. Sehgal, MD on December 29, 2020. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Alison R. Sehgal, MD
- Inspection Date: 2020-12-29
- Product Type: other
- Office Name: Philadelphia District Office
- Summary: An FDA inspection of Alison R. Sehgal, MD, a clinical investigator in Pittsburgh, revealed a significant deviation from an investigational plan. The firm failed to conduct a required repeat bone marrow assessment for a subject with known bone marrow involvement, despite reporting a complete response. This indicates a failure to adhere to established protocol for confirming treatment efficacy.

## Related Officers

- [Cynthia L. Rakestraw](https://www.keypedia.com/people/cynthia-l-rakestraw/ca138abf-e5d4-43ca-b9d2-79ea6294a8c8)

Company: https://www.keypedia.com/companies/alison-r-sehgal-md/7fdeb4f9-1334-414c-a4c8-cda454f50267

Office: https://www.keypedia.com/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8